linkedin

Press Releases

News Brief

Samsung Biologics issues first annual TCFD report

 Newsroom_TCFD%20Report.png 

 

Samsung Biologics published its first report aligned to the recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD). The report serves the company’s commitment to providing meaningful transparency on its approach to managing climate-related risks and opportunities across the business.

 

Last year, Samsung Biologics formally announced its commitment to achieving net zero GHG emissions in its own operations and in its entire supply chain by 2050 or earlier. The company also joined the RE100 initiative to transition its site to 100% renewable electricity. In addition to an environmental management strategy which includes process energy optimization, transitioning to renewable energy, and minimizing the use of disposables, Samsung Biologics has also proactively engaged with suppliers to reduce their direct emissions. 

 

The TCFD report represents an important step to deliver progress; climate change-impact assessments will be integrated into Samsung Biologics’ strategic planning and risk management frameworks to help strengthen its business resilience and adaptation to climate change. 

 

The full text of the 2022 Samsung Biologics TCFD Report can be viewed here.

 

 Newsroom_TCFD%20Report.png 

 

Samsung Biologics published its first report aligned to the recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD). The report serves the company’s commitment to providing meaningful transparency on its approach to managing climate-related risks and opportunities across the business.

 

Last year, Samsung Biologics formally announced its commitment to achieving net zero GHG emissions in its own operations and in its entire supply chain by 2050 or earlier. The company also joined the RE100 initiative to transition its site to 100% renewable electricity. In addition to an environmental management strategy which includes process energy optimization, transitioning to renewable energy, and minimizing the use of disposables, Samsung Biologics has also proactively engaged with suppliers to reduce their direct emissions. 

 

The TCFD report represents an important step to deliver progress; climate change-impact assessments will be integrated into Samsung Biologics’ strategic planning and risk management frameworks to help strengthen its business resilience and adaptation to climate change. 

 

The full text of the 2022 Samsung Biologics TCFD Report can be viewed here.

 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION